CME GROUP INC.
CME Group Inc. (formerly Chicago Mercantile Exchange Holdings Inc.), headquartered in Chicago, Illinois, operates exchanges and provides clearing services for trading in financial derivatives such as futures contracts, options, and swaps. Its exchanges include the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company also owns 27% of S&P Dow Jones Indices. The company operates the Globex Trading System, an electronic trading platform that allows customers in approximately 150 countries to trade futures and options contracts. The company also operates two platforms for spot market trading: BrokerTec, which facilitates dealer-to-dealer trading in fixed-income products, and EBS, which provides spot trading in foreign exchange markets. CME Clearing serves as a counterparty to every transaction cleared by the company.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- CME [1]
- Listing exchanges
- Nasdaq [1]
- SEC industry
- Security & Commodity Brokers, Dealers, Exchanges & Services [1]
- Business sectors
- finance [2]
- Company / filing name
- CME GROUP INC. [1]
- Headquarters location
- Chicago; London [2]
- Business address
- 20 S. WACKER DR., CHICAGO, IL, 60606 [1]
- Founded
- 2007-07-12 [2]
- Legal form
- Delaware corporation [2]
- Incorporation jurisdiction
- Delaware, United States [1]
- Official website
- www.cmegroup.com ↗ [2]
- Annual revenue
- USD 5,019,400,000 · reported year 2022 [2]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- US12572Q1058 [2]
- CIK
- 0001156375 [1]
- SIC code
- 6200 [1]
- Country in background record
- United States; United Kingdom [2]
Company positioning and business
CME Group Inc. (formerly Chicago Mercantile Exchange Holdings Inc.), headquartered in Chicago, Illinois, operates exchanges and provides clearing services for trading in financial derivatives such as futures contracts, options, and swaps. Its exchanges include the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company also owns 27% of S&P Dow Jones Indices. The company operates the Globex Trading System, an electronic trading platform that allows customers in approximately 150 countries to trade futures and options contracts. The company also operates two platforms for spot market trading: BrokerTec, which facilitates dealer-to-dealer trading in fixed-income products, and EBS, which provides spot trading in foreign exchange markets. CME Clearing serves as a counterparty to every transaction cleared by the company. [3]
Financial derivatives traded on CME's exchanges are tied to interest rates (primarily SOFR or United States Treasury securities; 51% of 2025 volume), stock market indexes (primarily E-mini contracts on the S&P 500 and Nasdaq-100; 26% of 2025 volume), energy-related products (primarily oil and natural gas; 10% of 2025 volume), agricultural products (primarily corn, soybeans, and wheat; 7% of 2025 volume), exchange currencies (primarily with the Euro, Japanese yen, British pound, and Australian dollar; 3% of 2025 volume), metals (primarily gold, silver, and copper; 3% of 2025 volume), and cryptocurrency (primarily Bitcoin and Ether; negligible volume in 2025). Institutional trading represents 85% to 90% of the company's trading volume. [3]
In 2025, 81% of the company's revenues were from clearing and transaction fees, 12% of revenues were from market data fees, and 7% of revenues were from other sources, primarily access and communication fees. In 2025, over 7 billion futures and options contracts were traded on the company's platforms; the company received average fees of $0.70 per contract traded. The company has witnessed increased trading volumes during periods of high market volatility. [3]
Background text: Wikipedia contributors, CME Group. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Understanding company scale
Annual revenue: USD 5,019,400,000 · reported year 2022. [2]
Financial year, securities and disclosures
The SEC submissions record gives CME GROUP INC. a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: CME (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 6200. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was CME GROUP INC. founded?
Founded: 2007-07-12. The linked source provides the background record. [2]
Where is the headquarters of CME GROUP INC.?
Headquarters location: Chicago; London. The linked source provides the background record. [2]
Which business sectors are recorded for CME GROUP INC.?
Business sectors: finance. The linked source provides the background record. [2]
CME GROUP INC. relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — CME GROUP INC. filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — CME Group (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.